{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:07:26Z","timestamp":1792130846065,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ovarian injury caused by chemotherapy can lead to early menopause, infertility, and even premature senility in female cancer patients, impairing the quality of life and overall health of the cancer survivors seriously. However, there is still a lack of effective protection strategies against such injury. Cellular senescence can be induced by chemotherapeutic agents in multiple organs and may corrode the structure and function of normal tissues. We hypothesized that the widely used first-line chemotherapy drug, doxorubicin, could increase senescent cell burden in normal ovarian tissue during the therapeutic process and that elimination of senescent cells with senolytics would ameliorate doxorubicin-induced ovarian injury. Here, we demonstrated an accumulation of cellular senescence in doxorubicin-treated ovaries through detecting p16 and p21 expression levels and senescence-associated \u03b2-galactosidase (SA-\u03b2-gal) activity as well as senescence-associated secretory phenotype (SASP) factors. Short-term intervention with the classic senolytic combination dasatinib and quercetin (DQ) or fisetin significantly reduced the load of senescent cells in ovaries after doxorubicin treatment. However, neither DQ nor fisetin alleviated doxorubicin-related ovarian dysfunction. Further experiments showed that ovarian apoptosis and fibrosis following doxorubicin exposure could not be improved by senolytics. Collectively, our study shows that senolytic treatment can eliminate accumulated senescent cells, but cannot reverse the massive follicle loss and ovarian stromal fibrosis caused by doxorubicin, suggesting that cellular senescence may not be one of the key mechanisms in doxorubicin-induced ovarian injury.<\/jats:p>","DOI":"10.1007\/s11357-023-00728-2","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T13:03:22Z","timestamp":1673960602000},"page":"1775-1790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics"],"prefix":"10.1007","volume":"45","author":[{"given":"Yueyue","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-952X","authenticated-orcid":false,"given":"Shixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"728_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21660.","DOI":"10.3322\/caac.21660"},{"key":"728_CR2","doi-asserted-by":"publisher","unstructured":"Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015. https:\/\/doi.org\/10.1056\/NEJMra1400972.","DOI":"10.1056\/NEJMra1400972"},{"key":"728_CR3","doi-asserted-by":"publisher","unstructured":"Sasaki K, Jabbour E, Short NJ, Jain N, Ravandi F, et al. Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017. Am J Hematol. 2021. https:\/\/doi.org\/10.1002\/ajh.26156.","DOI":"10.1002\/ajh.26156"},{"key":"728_CR4","doi-asserted-by":"publisher","unstructured":"Maajani K, Jalali A, Alipour S, Khodadost M, Tohidinik HR, et al. The global and regional survival rate of women with breast cancer: a systematic review and meta-analysis. Clin Breast Cancer. 2019. https:\/\/doi.org\/10.1016\/j.clbc.2019.01.006.","DOI":"10.1016\/j.clbc.2019.01.006"},{"key":"728_CR5","doi-asserted-by":"publisher","unstructured":"Brown PA, Shah B, Advani A, Aoun P, Boyer MW, et al. Acute Lymphoblastic leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021. https:\/\/doi.org\/10.6004\/jnccn.2021.0042.","DOI":"10.6004\/jnccn.2021.0042"},{"key":"728_CR6","doi-asserted-by":"publisher","unstructured":"Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Armand P, et al. NCCN guidelines(R) insights: Hodgkin lymphoma, Version 2.2022. J Natl Compr Canc Netw. 2022. https:\/\/doi.org\/10.6004\/jnccn.2022.0021.","DOI":"10.6004\/jnccn.2022.0021"},{"key":"728_CR7","doi-asserted-by":"publisher","unstructured":"Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020. https:\/\/doi.org\/10.6004\/jnccn.2020.0016.","DOI":"10.6004\/jnccn.2020.0016"},{"key":"728_CR8","doi-asserted-by":"publisher","unstructured":"van der Zanden SY, Qiao X, Neefjes J. New insights into the activities and toxicities of the old anticancer drug doxorubicin. FEBS J. 2021. https:\/\/doi.org\/10.1111\/febs.15583.","DOI":"10.1111\/febs.15583"},{"key":"728_CR9","doi-asserted-by":"publisher","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019. https:\/\/doi.org\/10.1093\/humupd\/dmz027.","DOI":"10.1093\/humupd\/dmz027"},{"key":"728_CR10","doi-asserted-by":"publisher","unstructured":"Demeestere I, Racape J, Dechene J, Dupuis J, Morschhauser F, et al. Gonadal function recovery in patients with advanced Hodgkin lymphoma treated with a PET-adapted regimen: prospective analysis of a randomized phase III trial (AHL2011). J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/JCO.21.00068.","DOI":"10.1200\/JCO.21.00068"},{"key":"728_CR11","doi-asserted-by":"publisher","unstructured":"Tuppi M, Kehrloesser S, Coutandin DW, Rossi V, Luh LM, et al. Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63. Nat Struct Mol Biol. 2018. https:\/\/doi.org\/10.1038\/s41594-018-0035-7.","DOI":"10.1038\/s41594-018-0035-7"},{"key":"728_CR12","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu M, Johnson SB, Yuan G, Arriba AK, et al. Doxorubicin obliterates mouse ovarian reserve through both primordial follicle atresia and overactivation. Toxicol Appl Pharmacol. 2019. https:\/\/doi.org\/10.1016\/j.taap.2019.114714.","DOI":"10.1016\/j.taap.2019.114714"},{"key":"728_CR13","doi-asserted-by":"publisher","unstructured":"Niringiyumukiza JD, Cai H, Chen L, Li Y, Wang L, et al. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve. Biomed Pharmacother. 2019. https:\/\/doi.org\/10.1016\/j.biopha.2019.108963.","DOI":"10.1016\/j.biopha.2019.108963"},{"key":"728_CR14","doi-asserted-by":"publisher","unstructured":"Kropp J, Roti Roti EC, Ringelstetter A, Khatib H, Abbott DH, et al. Dexrazoxane diminishes doxorubicin-induced acute ovarian damage and preserves ovarian function and fecundity in mice. PLoS One. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0142588.","DOI":"10.1371\/journal.pone.0142588"},{"key":"728_CR15","doi-asserted-by":"publisher","unstructured":"Donnez J, Dolmans MM. Fertility Preservation in Women. N Engl J Med. 2017. https:\/\/doi.org\/10.1056\/NEJMra1614676.","DOI":"10.1056\/NEJMra1614676"},{"key":"728_CR16","doi-asserted-by":"publisher","unstructured":"Xiong J, Xue L, Li Y, Tang W, Chen D, et al. Therapy of endocrine disease: novel protection and treatment strategies for chemotherapy-associated ovarian damage. Eur J Endocrinol. 2021. https:\/\/doi.org\/10.1530\/EJE-20-1178.","DOI":"10.1530\/EJE-20-1178"},{"key":"728_CR17","doi-asserted-by":"publisher","unstructured":"Herranz N, Gil J. Mechanisms and functions of cellular senescence. J Clin Invest. 2018. https:\/\/doi.org\/10.1172\/JCI95148.","DOI":"10.1172\/JCI95148"},{"key":"728_CR18","doi-asserted-by":"publisher","unstructured":"Calcinotto A, Kohli J, Zagato E, Pellegrini L, Demaria M, et al. Cellular senescence: aging, cancer, and injury. Physiol Rev. 2019. https:\/\/doi.org\/10.1152\/physrev.00020.2018.","DOI":"10.1152\/physrev.00020.2018"},{"key":"728_CR19","doi-asserted-by":"publisher","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015. https:\/\/doi.org\/10.1111\/acel.12344.","DOI":"10.1111\/acel.12344"},{"key":"728_CR20","doi-asserted-by":"publisher","unstructured":"Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018. https:\/\/doi.org\/10.1038\/s41591-018-0092-9.","DOI":"10.1038\/s41591-018-0092-9"},{"key":"728_CR21","doi-asserted-by":"publisher","unstructured":"Ogrodnik M, Evans SA, Fielder E, Victorelli S, Kruger P, et al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell. 2021. https:\/\/doi.org\/10.1111\/acel.13296.","DOI":"10.1111\/acel.13296"},{"key":"728_CR22","doi-asserted-by":"publisher","unstructured":"Novais EJ, Tran VA, Johnston SN, Darris KR, Roupas AJ, et al. Long-term treatment with senolytic drugs Dasatinib and Quercetin ameliorates age-dependent intervertebral disc degeneration in mice. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-25453-2.","DOI":"10.1038\/s41467-021-25453-2"},{"key":"728_CR23","doi-asserted-by":"publisher","unstructured":"Yousefzadeh MJ, Zhu Y, McGowan SJ, Angelini L, Fuhrmann-Stroissnigg H, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.015.","DOI":"10.1016\/j.ebiom.2018.09.015"},{"key":"728_CR24","doi-asserted-by":"publisher","unstructured":"Zhang L, Tong X, Huang J, Wu M, Zhang S, et al. Fisetin alleviated bleomycin-induced pulmonary fibrosis partly by rescuing alveolar epithelial cells from senescence. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.553690.","DOI":"10.3389\/fphar.2020.553690"},{"key":"728_CR25","doi-asserted-by":"publisher","unstructured":"Demaria M, O'Leary MN, Chang J, Shao L, Liu S, et al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov. 2017. https:\/\/doi.org\/10.1158\/2159-8290.Cd-16-0241.","DOI":"10.1158\/2159-8290.Cd-16-0241"},{"key":"728_CR26","doi-asserted-by":"publisher","unstructured":"L\u00e9rida-Viso A, Estepa- Fern\u00e1ndez A, Morell\u00e1-Aucejo \u00c1, Lozano-Torres B, Alfonso M, et al. Pharmacological senolysis reduces doxorubicin-induced cardiotoxicity and improves cardiac function in mice. Pharmacol Res. 2022. https:\/\/doi.org\/10.1016\/j.phrs.2022.106356.","DOI":"10.1016\/j.phrs.2022.106356"},{"key":"728_CR27","doi-asserted-by":"publisher","unstructured":"Li C, Shen Y, Huang L, Liu C, Wang J. Senolytic therapy ameliorates renal fibrosis postacute kidney injury by alleviating renal senescence. FASEB J. 2021. https:\/\/doi.org\/10.1096\/fj.202001855RR.","DOI":"10.1096\/fj.202001855RR"},{"key":"728_CR28","doi-asserted-by":"publisher","unstructured":"Iske J, Seyda M, Heinbokel T, Maenosono R, Minami K, et al. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-18039-x.","DOI":"10.1038\/s41467-020-18039-x"},{"key":"728_CR29","doi-asserted-by":"publisher","unstructured":"Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears. Toxicol Pathol. 2015. https:\/\/doi.org\/10.1177\/0192623315570339.","DOI":"10.1177\/0192623315570339"},{"key":"728_CR30","doi-asserted-by":"publisher","unstructured":"Bernstein LR, Mackenzie ACL, Kraemer DC, Morley JE, Farr S, et al. Shortened estrous cycle length, increased FSH levels, FSH variance, oocyte spindle aberrations, and early declining fertility in aging senescence-accelerated mouse prone-8 (SAMP8) mice: concomitant characteristics of human midlife female reproductive aging. Endocrinology. 2014. https:\/\/doi.org\/10.1210\/en.2013-2153.","DOI":"10.1210\/en.2013-2153"},{"key":"728_CR31","doi-asserted-by":"publisher","unstructured":"Zhang J, Fang L, Shi L, Lai Z, Lu Z, et al. Protective effects and mechanisms investigation of Kuntai capsule on the ovarian function of a novel model with accelerated aging ovaries. J Ethnopharmacol. 2017. https:\/\/doi.org\/10.1016\/j.jep.2016.11.014.","DOI":"10.1016\/j.jep.2016.11.014"},{"key":"728_CR32","doi-asserted-by":"publisher","unstructured":"Wang HL, Zhou ZG, Holmqvist A, Zhang H, Li Y, et al. Survivin expression quantified by Image Pro-Plus compared with visual assessment. Appl Immunohistochem Mol Morphol. 2009. https:\/\/doi.org\/10.1097\/PAI.0b013e3181a13bf2.","DOI":"10.1097\/PAI.0b013e3181a13bf2"},{"key":"728_CR33","doi-asserted-by":"publisher","unstructured":"Sun KH, Chang Y, Reed NI, Sheppard D. alpha-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFbeta activation or collagen production across multiple models of organ fibrosis. Am J Physiol Lung Cell Mol Physiol. 2016. https:\/\/doi.org\/10.1152\/ajplung.00350.2015.","DOI":"10.1152\/ajplung.00350.2015"},{"key":"728_CR34","doi-asserted-by":"publisher","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of cellular senescence. Trends Cell Biol. 2018. https:\/\/doi.org\/10.1016\/j.tcb.2018.02.001.","DOI":"10.1016\/j.tcb.2018.02.001"},{"key":"728_CR35","doi-asserted-by":"publisher","unstructured":"Aljobaily N, Viereckl MJ, Hydock DS, Aljobaily H, Wu TY, et al. Creatine alleviates doxorubicin-induced liver damage by inhibiting liver fibrosis, inflammation, oxidative stress, and cellular senescence. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu13010041.","DOI":"10.3390\/nu13010041"},{"key":"728_CR36","doi-asserted-by":"publisher","unstructured":"Yang HL, Hsieh PL, Hung CH, Cheng HC, Chou WC, et al. Early moderate intensity aerobic exercise intervention prevents doxorubicin-caused cardiac dysfunction through inhibition of cardiac fibrosis and inflammation. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12051102.","DOI":"10.3390\/cancers12051102"},{"key":"728_CR37","doi-asserted-by":"publisher","unstructured":"Overbeek A, van den Berg MH, van Leeuwen FE, Kaspers GJ, Lambalk CB, et al. Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review. Cancer Treat Rev. 2017. https:\/\/doi.org\/10.1016\/j.ctrv.2016.11.006.","DOI":"10.1016\/j.ctrv.2016.11.006"},{"key":"728_CR38","doi-asserted-by":"publisher","unstructured":"Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016. https:\/\/doi.org\/10.1093\/humrep\/dew027.","DOI":"10.1093\/humrep\/dew027"},{"key":"728_CR39","doi-asserted-by":"publisher","unstructured":"Marino Gammazza A, Campanella C, Barone R, Caruso Bavisotto C, Gorska M, et al. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60\/p53 complex dissociation and instauration of replicative senescence. Cancer Lett. 2017. https:\/\/doi.org\/10.1016\/j.canlet.2016.10.045.","DOI":"10.1016\/j.canlet.2016.10.045"},{"key":"728_CR40","doi-asserted-by":"publisher","unstructured":"Karabicici M, Alptekin S, F\u0131rt\u0131na Karagonlar Z, Erdal E. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM\u2212\/CD133\u2212 nonstem cell population in hepatocellular carcinoma cell line, HuH-7. Mol Oncol. 2021. https:\/\/doi.org\/10.1002\/1878-0261.12916.","DOI":"10.1002\/1878-0261.12916"},{"key":"728_CR41","doi-asserted-by":"publisher","unstructured":"Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017. https:\/\/doi.org\/10.1038\/nm.4385.","DOI":"10.1038\/nm.4385"},{"key":"728_CR42","doi-asserted-by":"publisher","unstructured":"Palmer AK, Xu M, Zhu Y, Pirtskhalava T, Weivoda MM, et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 2019. https:\/\/doi.org\/10.1111\/acel.12950.","DOI":"10.1111\/acel.12950"},{"key":"728_CR43","doi-asserted-by":"publisher","unstructured":"Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/ncomms14532.","DOI":"10.1038\/ncomms14532"},{"key":"728_CR44","doi-asserted-by":"publisher","unstructured":"Wang H, Wang Z, Huang Y, Zhou Y, Sheng X, et al. Senolytics (DQ) mitigates radiation ulcers by removing senescent cells. Front Oncol. 2019. https:\/\/doi.org\/10.3389\/fonc.2019.01576.","DOI":"10.3389\/fonc.2019.01576"},{"key":"728_CR45","doi-asserted-by":"publisher","unstructured":"Saito Y, Miyajima M, Yamamoto S, Sato T, Miura N, et al. Accumulation of senescent neural cells in murine lupus with depression-like behavior. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.692321.","DOI":"10.3389\/fimmu.2021.692321"},{"key":"728_CR46","doi-asserted-by":"publisher","unstructured":"Alsuraih M, O'Hara SP, Woodrum JE, Pirius NE, LaRusso NF. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the Mdr2 (-\/-) mouse. JHEP Rep. 2021. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100250.","DOI":"10.1016\/j.jhepr.2021.100250"},{"key":"728_CR47","doi-asserted-by":"publisher","unstructured":"Kim SG, Sung JY, Kim JR, Choi HC. Fisetin-induced PTEN expression reverses cellular senescence by inhibiting the mTORC2-Akt Ser473 phosphorylation pathway in vascular smooth muscle cells. Exp Gerontol. 2021. https:\/\/doi.org\/10.1016\/j.exger.2021.111598.","DOI":"10.1016\/j.exger.2021.111598"},{"key":"728_CR48","doi-asserted-by":"publisher","unstructured":"Justice JN, Nambiar AM, Tchkonia T, LeBrasseur NK, Pascual R, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019. https:\/\/doi.org\/10.1016\/j.ebiom.2018.12.052.","DOI":"10.1016\/j.ebiom.2018.12.052"},{"key":"728_CR49","doi-asserted-by":"publisher","unstructured":"Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069.","DOI":"10.1016\/j.ebiom.2019.08.069"},{"key":"728_CR50","doi-asserted-by":"publisher","unstructured":"Ren X, Bo Y, Fan J, Chen M, Xu D, et al. Dalbergioidin ameliorates doxorubicin-induced renal fibrosis by suppressing the TGF-beta signal pathway. Mediat Inflamm. 2016. https:\/\/doi.org\/10.1155\/2016\/5147571.","DOI":"10.1155\/2016\/5147571"},{"key":"728_CR51","doi-asserted-by":"publisher","unstructured":"Pan J, Zhang H, Lin H, Gao L, Zhang H, et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells. Redox Biol. 2021. https:\/\/doi.org\/10.1016\/j.redox.2021.102120.","DOI":"10.1016\/j.redox.2021.102120"},{"key":"728_CR52","doi-asserted-by":"publisher","unstructured":"Du D, Tang X, Li Y, Gao Y, Chen R, et al. Senotherapy protects against cisplatin-induced ovarian injury by removing senescent cells and alleviating DNA damage. Oxid Med Cell Longev. 2022. https:\/\/doi.org\/10.1155\/2022\/9144644.","DOI":"10.1155\/2022\/9144644"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00728-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-023-00728-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-00728-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T10:23:40Z","timestamp":1691058220000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-023-00728-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s11357-023-00728-2","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"18 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All protocols and experimental procedures in this study were approved by the Laboratory Animal Welfare & Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology in the People\u2019s Republic of China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}